Introducing The Thermo Scientific Prima BT Bench Top Mass Spectrometer
A new benchtop mass spectrometer is designed to offer process lab researchers, managers, and engineers fast and precise gas analysis by incorporating a magnetic sector analyzer designed for continuous operation in process development laboratories. The Thermo Scientific Prima BT Bench top Mass Spectrometer employs powerful scanning magnetic-sector technology. The system is designed to deliver superior analytical performance with high reliability and minimal maintenance requirements. Learn more.
By Maik W. Jornitz, Chief Operating Officer, G-CON Manufacturing LLC
Process equipment choices, whether multiuse or single-use, are commonly made early in the medicinal drug development activities, and in test labs. Choices made in the test lab about which equipment would be tested are often dependent on either the availability of the equipment or knowledge about it. This often results in a legacy equipment choice. However, since the volumes used within the early drug development stages are very small, the process equipment used might not represent the process scale design or, even worse, is not scalable to process volumes. A proper plan and scalability investigation should precede the choice and testing of equipment, especially when being single-use.
Bioresearch Online is proud to announce the launch of our sister company, the Life Science Training Institute (LSTI). LSTI is committed to bringing you the highest quality training courses by blending the interactivity of the classroom with the affordability and convenience of online training. Click on a course below to find out more.
By Bobby Chavli, Associate Director of Marketing BD and Customer Service for Hamilton Robotics; and Mary Napier, Scientific Writer and Consultant for GeneCom Group
Some labs assume that PCR (polymerase chain reaction) automation is too expensive or difficult, but today's solutions are more cost-effective and easy to achieve than you might think. Learn the many benefits available through automating your PCR process.
By Pete Brescia, Brad Larson, and Peter Banks, BioTek Instruments, Inc.; and D. Bochar and L. Blazer, Cayman Chemical Co.
Post-translational histone modifications are critical for modulation of chromatin structure by direct DNA interaction and indirect molecular interactions with recruited nuclear proteins.
By Patrik O. Michel, Ph.D.; Christophe Degen; Melanie Hubert; Lucia Baldi, Ph.D.; David L. Hacker, Ph.D.; and Florian M. Wurm, Ph.D.
Thermo Scientific™ NanoDrop™ spectrophotometers are the gold standard for the quantification and analysis of nucleic acids and proteins; however, there are a variety of other applications to which they are well suited.
By Arthur Papineau, BS ChE, MBA; and John Klostermyer, Ph.D., STERIS Life Sciences
Whether it is a new laboratory research facility or renovation of an existing facility, a sound commissioning process is vital to start-up success.
By Alan E. George, ILC Dover
This article provides a review of various innovative solutions, a provocative thought process for customized installations if needed, and a look at a technology verified to reduce the overall cost of ownership for contained processing.
By Dave Bode, VP; Health Care Solutions – DSC Logistics
Innovation defines a wide range of initiatives that supply chain leaders in life sciences companies are pursuing to best help their organizations meet the fundamental changes occurring in the industry: heightened regulatory enforcement, outcomes-based reimbursement, consumer-centric vs. provider-centric care, increased access to care, and new taxes. The magnitude of these changes was made perfectly clear at a healthcare conference hosted by Gartner in November, 2012. The keynote speaker, Don Cassey, CEO, Medical Segment, Cardinal Health, declared that the healthcare industry must reduce its cost by 30 percent in order to remain sustainable. To put this in perspective, this means that the US healthcare system would need to shed $5 Trillion in operating cost. The need and value of step change innovation in the healthcare industry will never be higher.
By Michael Gotz, Director of Dangerous Goods Quick Group of Companies, QuickSTAT
Transportation of biological substances and infectious materials has become increasingly challenging. Understanding the Dangerous Goods Classification requirements is critical to ensure that your shipments are in compliance with the law.
IBC's Cell Therapy Bioprocessing conference (October 21 and 22, 2013, in Bethesda, MD) offers the latest data on the industry pipeline, business models, metrics, and trends to advance your cell therapy program towards commercial success. Download the Brochure